<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02967315</url>
  </required_header>
  <id_info>
    <org_study_id>2013-0276</org_study_id>
    <nct_id>NCT02967315</nct_id>
  </id_info>
  <brief_title>Effects of Changes in Fluid Status on Right Ventricular Volumes and Function</brief_title>
  <official_title>Effects of Changes in Fluid Status on Right Ventricular Volumes and Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the correlation between fluid volume status and
      right ventricular volume and function, in those with free pulmonary valve insufficiency after
      Tetralogy of Fallot (TOF) repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to measure the changes in Right Ventricular size and function
      with changes in preload, using cardiovascular magnetic resonance (CMR). Based on an intensive
      research and clinical observations the investigators hypothesize that changes in volume
      status cause a statistically significant difference in the Cardiovascular magnetic resonance
      (CMR) measured RV End Diastolic Volume (EDV), end-systolic volume (ESV), ejection fraction
      (EF) and pulmonary regurgitation (PR). The investigator hypothesizes that smaller changes
      will occur in left ventricular LV EDV, ESV, and EF.

        1. To establish a correlation between the changes in preload volume status and RV size and
           function in patients with free pulmonary insufficiency (PI) after TOF repair using CMRI.

        2. To assess the effects of preload status on the measured severity of pulmonary
           regurgitation (PR).

        3. To assess the effects of preload status on the left ventricular (LV) size

      This study will be conducted in compliance with this protocol, good clinical practice and the
      applicable regulatory requirements.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postload volume status</measure>
    <time_frame>24 months</time_frame>
    <description>The following will be measured to define the postload volume status: Left and right ventricle end diastolic volume (milliliters [ml]); Ejection fraction (%); pulmonary regurgitation</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Tetralogy of Fallot</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedures include:
Two Cardiac Magnetic Resonance Imaging (CMRIs) A central venous line placement, A chest X-ray Electrocardiogram (ECG) Fluid administration Blood draw Pregnancy test</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac Magnetic Resonance Imaging (CMRI)</intervention_name>
    <description>There will be 2 CMRIs. The first one will be patient's routine clinically schedule CMRI after the patient has fasted for 12 hours.This CMRI uses contrast.
The second CMRI will be the research CMRI after the fluid administration. This CMRI does not use contrast.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Central venous line placement</intervention_name>
    <description>An ultrasound guided central line catheter will be placed in the internal jugular vein (IJV) under local anesthesia.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Chest X-ray</intervention_name>
    <description>A chest X-ray will be performed for safety reasons to rule out pneumothorax (&lt; 1% risk) after central line placement.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluid administration</intervention_name>
    <description>Administration of 15cc/kg of normal saline for fluid hydration through peripheral IV that is placed for the MRI contrast administration.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood Draw</intervention_name>
    <description>One to two teaspoons of blood will be drawn for basic metabolic panel.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pregnancy test</intervention_name>
    <description>A urine pregnancy test will be performed in female subjects.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electrocardiogram</intervention_name>
    <description>12 lead ECG</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. TOF patients who have had repair using a transannular patch.

          2. Patients that present with free pulmonary insufficiency.

          3. Are older than 18 years.

        Exclusion Criteria:

          1. Patients who have lesions predisposing to chronic volume overload (i.e. patients with
             significant residual postoperative ventricular septal defects (VSD), or large
             aorto-pulmonary collaterals or more than moderate tricuspid insufficiency) since all
             these hemodynamic conditions can influence the late function of the right ventricle
             and potentially affect the response of the right side of the heart in changes in
             volume status

          2. Patients who had a valve sparing TOF repair and have less than free pulmonary
             insufficiency.

          3. Patients who have significant residual right-sided obstruction (i.e. patients who have
             residual RVOT obstruction or significant residual branch pulmonary artery stenosis),
             as it is shown that residual pulmonary stenosis may protect from RV dilation and from
             deterioration of the RV function.

          4. Patients who cannot be reconstructed with a transannular patch and/or require a right
             ventricle to pulmonary artery homograft for reconstruction including:

               -  pulmonary atresia and VSD

               -  patients with anomalous coronary crossing the right ventricular outflow tract
                  (RVOT) and

               -  patients with TOF-absent pulmonary valve syndrome.

          5. Patients with renal failure and renal insufficiency

          6. Patients with uncompensated heart failure

          7. Cancer patients

          8. Latex allergic patients

          9. Patients with diabetes

         10. Pregnant females

         11. Prisoners

         12. Individuals who lack consent capacity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petros V Anagnostopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Entela B Lushaj, MD, PhD</last_name>
    <phone>608-263-5221</phone>
    <email>lushaj@surgery.wisc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Wisconsin-Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Entela B Lushaj, MD, PhD</last_name>
      <phone>608-263-5221</phone>
      <email>lushaj@surgery.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Petros V Anagnostopoulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2016</study_first_submitted>
  <study_first_submitted_qc>November 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2016</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetralogy of Fallot</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

